Iovance Biotherapeutics, Inc. (IOVA)
2.27
+0.05
(+2.25%)
USD |
NASDAQ |
Jan 16, 11:37
Iovance Biotherapeutics Market Cap: 901.12M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 37.45M |
| Intellia Therapeutics, Inc. | 1.464B |
| Perspective Therapeutics, Inc. | 179.15M |
| Electromed, Inc. | 236.29M |
| InfuSystem Holdings, Inc. | 177.33M |
Market Cap Related Metrics
| PS Ratio | 3.006 |
| Price to Book Value | 1.283 |
| Price | 2.27 |
| Earnings Yield | -52.95% |